| 000 | 01883 a2200541 4500 | ||
|---|---|---|---|
| 005 | 20250514200912.0 | ||
| 264 | 0 | _c20050411 | |
| 008 | 200504s 0 0 eng d | ||
| 022 | _a1524-4539 | ||
| 024 | 7 |
_a10.1161/01.CIR.0000141726.01302.83 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBibbins-Domingo, Kirsten | |
| 245 | 0 | 0 |
_aPredictors of heart failure among women with coronary disease. _h[electronic resource] |
| 260 |
_bCirculation _cSep 2004 |
||
| 300 |
_a1424-30 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aBlack or African American |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAtrial Fibrillation _xepidemiology |
| 650 | 0 | 4 |
_aBundle-Branch Block _xepidemiology |
| 650 | 0 | 4 | _aCohort Studies |
| 650 | 0 | 4 | _aComorbidity |
| 650 | 0 | 4 |
_aCoronary Disease _xcomplications |
| 650 | 0 | 4 |
_aDiabetes Mellitus _xepidemiology |
| 650 | 0 | 4 |
_aEstrogens, Conjugated (USP) _xadministration & dosage |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 |
_aHeart Failure _xepidemiology |
| 650 | 0 | 4 | _aHormone Replacement Therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypertension _xepidemiology |
| 650 | 0 | 4 |
_aHypertrophy, Left Ventricular _xepidemiology |
| 650 | 0 | 4 |
_aKidney Diseases _xepidemiology |
| 650 | 0 | 4 |
_aMedroxyprogesterone Acetate _xadministration & dosage |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aObesity _xepidemiology |
| 650 | 0 | 4 | _aPostmenopause |
| 650 | 0 | 4 | _aProportional Hazards Models |
| 650 | 0 | 4 | _aRandomized Controlled Trials as Topic |
| 650 | 0 | 4 | _aRisk Factors |
| 700 | 1 | _aLin, Feng | |
| 700 | 1 | _aVittinghoff, Eric | |
| 700 | 1 | _aBarrett-Connor, Elizabeth | |
| 700 | 1 | _aHulley, Stephen B | |
| 700 | 1 | _aGrady, Deborah | |
| 700 | 1 | _aShlipak, Michael G | |
| 773 | 0 |
_tCirculation _gvol. 110 _gno. 11 _gp. 1424-30 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1161/01.CIR.0000141726.01302.83 _zAvailable from publisher's website |
| 999 |
_c15048980 _d15048980 |
||